End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.55 CNY | +1.61% | +2.33% | +17.86% |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Appliances, Tools & Housewares
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.86% | 449M | - | ||
+30.31% | 31.39B | C | ||
+47.64% | 7.71B | C+ | ||
+103.04% | 7.03B | - | ||
-28.95% | 4.73B | B- | ||
+27.32% | 4.13B | C- | ||
+44.67% | 3.53B | A | ||
+14.69% | 3.45B | B+ | ||
+17.45% | 3.34B | B- | ||
-2.45% | 3B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603579 Stock
- Ratings Shanghai Rongtai Health Technology Corporation Limited